{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T11:47:54Z","timestamp":1788608874644,"version":"build-2803163510"},"reference-count":35,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Dermatologic Clinics"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.det.2019.05.006","type":"journal-article","created":{"date-parts":[[2019,8,26]],"date-time":"2019-08-26T18:03:30Z","timestamp":1566842610000},"page":"483-488","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":112,"title":["Dermatofibrosarcoma Protuberans"],"prefix":"10.1016","volume":"37","author":[{"given":"Aubrey","family":"Allen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar P.","family":"Sang\u00fceza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.det.2019.05.006_bib1","series-title":"Textbook of uncommon cancer","first-page":"994","article-title":"Dermatofibrosarcoma protuberans","author":"Luu","year":"2017"},{"issue":"3","key":"10.1016\/j.det.2019.05.006_bib2","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1002\/cncr.23571","article-title":"Cutaneous soft tissue sarcoma incidence patterns in the US","volume":"113","author":"Rouhani","year":"2008","journal-title":"Cancer"},{"issue":"12","key":"10.1016\/j.det.2019.05.006_bib3","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1111\/jdv.14378","article-title":"Wide local excision vs. Mohs T\u00fcbingen technique in the treatment of dermatofibrosarcoma protuberans: a two-centre retrospective study and literature review","volume":"31","author":"Veronese","year":"2017","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"1","key":"10.1016\/j.det.2019.05.006_bib4","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s12957-016-1075-2","article-title":"A\u00a0single-institutional review of 68 patients with dermatofibrosarcoma protuberans: wide re-excision after inadequate previous surgery results in a high rate of local control","volume":"15","author":"Harati","year":"2017","journal-title":"World J Surg Oncol"},{"issue":"17","key":"10.1016\/j.det.2019.05.006_bib5","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1016\/j.ejca.2015.06.108","article-title":"Diagnosis and treatment of dermatofibrosarcoma protuberans. European consensus-based interdisciplinary guideline","volume":"51","author":"Saiag","year":"2015","journal-title":"Eur J Cancer"},{"issue":"12","key":"10.1016\/j.det.2019.05.006_bib6","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1001\/jamadermatol.2015.2389","article-title":"A\u00a0novel chromosomal translocation associated with COL1A2-PDGFB gene fusion in dermatofibrosarcoma protuberans: PDGF expression as a new diagnostic tool","volume":"151","author":"Nakamura","year":"2015","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.det.2019.05.006_bib7","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.ctrv.2008.06.002","article-title":"Dermatofibrosarcoma protuberans: wide local excision vs. Mohs micrographic surgery","volume":"34","author":"Paradisi","year":"2008","journal-title":"Cancer Treat Rev"},{"issue":"3","key":"10.1016\/j.det.2019.05.006_bib8","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/PAS.0000000000000998","article-title":"Dermatofibrosarcoma protuberans of distal extremities and acral sites","volume":"42","author":"Shah","year":"2018","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"10.1016\/j.det.2019.05.006_bib9","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/S0190-9622(97)70179-8","article-title":"Mohs micrographic surgery for the treatment of dermatofibrosarcoma protuberans: results of a multiinstitutional series with an analysis of the extent of microscopic spread","volume":"37","author":"Ratner","year":"1997","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.det.2019.05.006_bib10","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/2045-3329-2-4","article-title":"Fibrosarcomatous changes and expression of CD34+ and apolipoprotein\u2013D in dermatofibrosarcoma protuberans","volume":"2","author":"Palmerini","year":"2012","journal-title":"Clin Sarcoma Res"},{"key":"10.1016\/j.det.2019.05.006_bib11","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.jaad.2014.11.020","article-title":"Prognostic impact of fibrosarcomatous transformation in dermatofibrosarcoma protuberans: a cohort study","volume":"72","author":"Hoesly","year":"2015","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.det.2019.05.006_bib12","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1097\/00000478-200604000-00002","article-title":"The prognostic significance of fibrosarcomatous transformation in dermatofibrosarcoma protuberans","volume":"30","author":"Abbott","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.det.2019.05.006_bib13","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1002\/ijc.25826","article-title":"Dermatofibrosarcoma protuberans-derived fibrosarcoma: clinical history, biological profile and sensitivity to imatinib","volume":"129","author":"Stacchiotti","year":"2011","journal-title":"Int J Cancer"},{"issue":"10","key":"10.1016\/j.det.2019.05.006_bib14","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1111\/cup.12203","article-title":"High immunohistochemical nestin expression is associated with greater depth of infiltration in dermatofibrosarcoma protuberans: a study of 71 cases","volume":"40","author":"Serra-Guill\u00e9n","year":"2013","journal-title":"J\u00a0Cutan Pathol"},{"key":"10.1016\/j.det.2019.05.006_bib15","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/modpathol.2009.176","article-title":"D2-40, a novel immunohistochemical marker in differentiating dermatofibroma from dermatofibrosarcoma protuberans","volume":"23","author":"Bandarchi","year":"2010","journal-title":"Mod Pathol"},{"issue":"7","key":"10.1016\/j.det.2019.05.006_bib16","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/j.1346-8138.2008.00496.x","article-title":"Expression of nestin in dermatofibrosarcoma protuberans in comparison to dermatofibroma","volume":"35","author":"Mori","year":"2008","journal-title":"J\u00a0Dermatol"},{"key":"10.1016\/j.det.2019.05.006_bib17","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.1600-0560.2010.01670.x","article-title":"Expression of embryonic stem cell markers SOX2 and nestin in dermatofibrosarcoma protuberans and dermatofibroma","volume":"38","author":"Sellheyer","year":"2011","journal-title":"J\u00a0Cutan Pathol"},{"issue":"6","key":"10.1016\/j.det.2019.05.006_bib18","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1111\/j.1365-2133.2009.09363.x","article-title":"Dermatofibrosarcoma protuberans: a tumour of nestin-positive cutaneous mesenchymal stem cells?","volume":"161","author":"Sellheyer","year":"2009","journal-title":"Br J Dermatol"},{"issue":"9","key":"10.1016\/j.det.2019.05.006_bib19","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/s11864-017-0498-5","article-title":"Dermatofibrosarcoma protuberans","volume":"18","author":"Acosta","year":"2017","journal-title":"Curr Treat Options Oncol"},{"key":"10.1016\/j.det.2019.05.006_bib20","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/0190-9622(95)90132-9","article-title":"Surgical margins for excision of dermatofibrosarcoma protuberans","volume":"32","author":"Parker","year":"1995","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.det.2019.05.006_bib21","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1245\/s10434-010-1046-8","article-title":"Dermatofibrosarcoma protuberans: how wide should we resect?","volume":"17","author":"Farma","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.det.2019.05.006_bib22","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1245\/s10434-010-1316-5","article-title":"Dermatofibrosarcoma protuberans (DFSP): predictors of recurrence and the use of systemic therapy","volume":"18","author":"Fields","year":"2011","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.det.2019.05.006_bib23","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.bjps.2013.01.016","article-title":"Reducing surgical margins in dermatofibrosarcoma protuberans using the pathological analysis technique \u2018vertical modified technique\u2019: a 5-year experience","volume":"66","author":"Hersant","year":"2013","journal-title":"J\u00a0Plast Reconstr Aesthet Surg"},{"key":"10.1016\/j.det.2019.05.006_bib24","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.bjps.2015.10.027","article-title":"Long-term outcomes of surgical treatment for dermatofibrosarcoma protuberans according to width of gross resection margin","volume":"69","author":"Woo","year":"2016","journal-title":"J\u00a0Plast Reconstr Aesthet Surg"},{"key":"10.1016\/j.det.2019.05.006_bib25","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1001\/jamadermatol.2016.3226","article-title":"Prognostic factors, treatment, and survival in dermatofibrosarcoma protuberans","volume":"152","author":"Criscito","year":"2016","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.det.2019.05.006_bib26","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/cncr.20316","article-title":"Dermatofibrosarcoma protuberans: a report on 29 patients treated by Mohs micrographic surgery with long-term follow-up and review of the literature","volume":"101","author":"Snow","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.det.2019.05.006_bib27","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/DSS.0000000000000910","article-title":"A\u00a0comparison of Mohs micrographic surgery and wide local excision for treatment of dermatofibrosarcoma protuberans with long-term follow-up: the Mayo Clinic experience","volume":"43","author":"Lowe","year":"2017","journal-title":"Dermatol Surg"},{"issue":"9","key":"10.1016\/j.det.2019.05.006_bib28","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1111\/j.1524-4725.1998.tb04293.x","article-title":"A\u00a0comparison of frozen and paraffin sections in dermatofibrosarcoma protuberans","volume":"24","author":"Massey","year":"1998","journal-title":"Dermatol Surg"},{"issue":"2","key":"10.1016\/j.det.2019.05.006_bib29","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.1524-4725.1996.tb00503.x","article-title":"Dermatofibrosarcoma protuberans treated with Mohs surgery. A case with CD34 immunostaining variability","volume":"22","author":"Garcia","year":"1996","journal-title":"Dermatol Surg"},{"issue":"4","key":"10.1016\/j.det.2019.05.006_bib30","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1200\/JCO.2005.07.088","article-title":"Molecular and clinical analysis of locally advanced dermatofibrosarcoma protuberans treated with imatinib: Imatinib Target Exploration Consortium Study B2225","volume":"23","author":"McArthur","year":"2005","journal-title":"J\u00a0Clin Oncol"},{"issue":"10","key":"10.1016\/j.det.2019.05.006_bib31","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1200\/JCO.2009.25.7899","article-title":"Imatinib mesylate in advanced dermatofibrosarcoma protuberans: pooled analysis of two phase II clinical trials","volume":"28","author":"Rutkowski","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"issue":"3","key":"10.1016\/j.det.2019.05.006_bib32","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/j.1468-3083.2010.03774.x","article-title":"Treatment of advanced dermatofibrosarcoma protuberans with imatinib mesylate with or without surgical resection","volume":"25","author":"Rutkowski","year":"2011","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"18_suppl","key":"10.1016\/j.det.2019.05.006_bib33","doi-asserted-by":"crossref","first-page":"10032","DOI":"10.1200\/jco.2007.25.18_suppl.10032","article-title":"Imatinib mesylate as a preoperative therapy in dermatofibrosarcoma: results of a multicentric phase II study on 25 patients","volume":"25","author":"Misset","year":"2007","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.det.2019.05.006_bib34","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1158\/1078-0432.CCR-13-1411","article-title":"Neoadjuvant imatinib in advanced primary or locally recurrent dermatofibrosarcoma protuberans: a multicenter phase II DeCOG trial with long-term follow-up","volume":"20","author":"Ugurel","year":"2014","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.det.2019.05.006_bib35","first-page":"8288","article-title":"Sunitinib for patients with locally advanced or distantly metastatic dermatofibrosarcoma protuberans but resistant to imatinib","volume":"8","author":"Fu","year":"2015","journal-title":"Int J Clin Exp Med"}],"container-title":["Dermatologic Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733863519300488?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733863519300488?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T10:44:44Z","timestamp":1760006684000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0733863519300488"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["S0733863519300488"],"URL":"https:\/\/doi.org\/10.1016\/j.det.2019.05.006","relation":{},"ISSN":["0733-8635"],"issn-type":[{"value":"0733-8635","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dermatofibrosarcoma Protuberans","name":"articletitle","label":"Article Title"},{"value":"Dermatologic Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.det.2019.05.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}